102. Rubinstein-Taybi syndrome Clinical trials / Disease details


Clinical trials : 3 Drugs : 8 - (DrugBank : 1) / Drug target genes : 7 - Drug target pathways : 17

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2011-003784-30-FR
(EUCTR)
13/12/2011Rubinstein-Taybi syndrome: approach to functional imaging and therapeutic trialRubinstein-Taybi syndrome: approach to functional imaging and therapeutic trial - RUBIVAL Rubinstein-Taybi Syndrome
MedDRA version: 14.1;Level: PT;Classification code 10039281;Term: Rubinstein-Taybi syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Trade Name: DepakineCHU de bordeauxNULLNAFemale: yes
Male: yes
Phase 2France